A new federal initiative aims to lower GLP-1 medication costs for Medicare beneficiaries. Learn what it means for coverage, pricing, and the future of obesity care.
Read More
Check out what’s happening with CHESS and the industry as more health care systems make the move to value. CHESS is committed to keeping our clients and colleagues up to date on the latest news in the new world of value-based health care.
A new federal initiative aims to lower GLP-1 medication costs for Medicare beneficiaries. Learn what it means for coverage, pricing, and the future of obesity care.
Read More
The DEA has signaled a fourth extension of telemedicine flexibilities for prescribing controlled substances, pushing the deadline into 2026. This move preserves uninterrupted patient access while giving clinicians, pharmacists and health system leaders more time to prepare for the agency’s forthcoming long-term rules.
Read More
When used correctly, G-codes can make a meaningful difference in how Medicaid services are documented, understood, and reimbursed.
Read More
By incorporating CCM and PCM into workflows, providers can deliver more consistent, coordinated, and compassionate care.
Read More
CMS has issued new guidance to tighten oversight of Medicaid financing, placing limits on certain provider taxes and closing funding gaps. These changes aim to create a more stable foundation for value based care so providers can focus on quality, prevention and better outcomes for patients.
Read More
CMS’s 2026 Medicare Fee Schedule brings a 3.85% pay bump, major changes to telehealth, skin substitutes, ASP drug pricing, and digital health policy.
Read More